MICROCAPSULES

Comprehensive particle size, stability and degradation analysis, fast development and quality control for emulsions and capsules.

Read more

DRUG DELIVERY

Size distribution, composition, loading and stability of your drug delivery systems in biological fluids as plasma/blood.

Read more

SLURRIES

Analyse and monitor the behaviour, structure and stability of compact and mesoporous particles employed as abrasives or agrochemicals.

Read more

PIGMENTS AND INKS

Obtain a thorough characterization of pigments for cosmetics, paints and inks! Speed up the R&D and Quality Control processes!

Read more

MINERAL POWDERS

Classify non spherical particles retrieving simultaneously particle aspect ratio distribution and numerical particle size distribution.

Read more

ENVIRONMENT

Analyse dust and mineral particles with an innovative point of view and improve your research on the environmental changes.

Read more

NOT NEWS: SPES/SPES^2 methods provide unique data and optical characterization on influence of radiative properties of inhomogeneous particles with internal structure of (eg. aggregates, mesoporous particles, …).

We are hiring:
Sale Engineer / Tecnico Commerciale
Production Technician / Tecnico Produzione

SPES Technology

SPES (Single Particle Extinction and Scattering) is an innovative patented technology for the characterization and development of subvisible/submicron particles in industrial, environmental and biological complex fluids.

Read more

CLASSIZER™ ONE

EOS develops enabling multiparametric platforms based on SPES patented technology for the development, formulation and quality control of novel classes of products based on the use of subvisible particless.

Read more

Contract Analysis Lab

EOS team is available for providing dedicated services and support in the research, development and quality control of your innovative products based on subvisible particles in simple and complex fluids.

Read more

euflagThis project has received funding from the European Union’s H2020 SME Instruments
Phase 1 research and innovation programme under grant agreement No 781906